{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-006113","form_type":"8-K","ticker":"CPMD","cik":"0001081938","company_name":"CANNAPHARMARX, INC.","filed_at":"2023-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.094935+00:00","generated_at":"2026-06-11T02:47:40.610655+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"CannaPharmaRx expands board to five; Branson resigns, Panek and Mindle appointed","bullets":["Mark Branson resigned from board effective March 23, 2023, not due to any dispute.","Board expanded from three to five seats; Anthony Panek and Adam Mindle appointed August 15, 2023.","Panek is a corporate M&A attorney and venture capital investor with cannabis experience.","Mindle is a transactional attorney with extensive real estate, finance, and M&A experience.","Both Panek and Mindle have applied for Health Canada clearance to serve as directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-006113","json":"https://secwatch.observer/filing/0001683168-23-006113.json","markdown":"https://secwatch.observer/filing/0001683168-23-006113.md","text":"https://secwatch.observer/filing/0001683168-23-006113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823006113/0001683168-23-006113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823006113/cannapharmarx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T02:47:40.610655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"037b6ee4e4","claim":"Mark Branson resigned as Director at CANNAPHARMARX, INC..","evidence_excerpt":"On March 23, 2023, Mark Branson informed the Board of Directors (the “Board”) of CannaPharmaRx, Inc. (the “Company”) that he intends to resign as a member of the Board effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823006113/0001683168-23-006113-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b8bc7c1baa","claim":"Anthony Michael Panek was appointed as Director at CANNAPHARMARX, INC..","evidence_excerpt":"On August 15th, 2023, the remaining members of the Board appointed Messrs. Adam Mindle and Anthony Michael Panek as members of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823006113/0001683168-23-006113-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ccab8b1534","claim":"Adam Mindle was appointed as Director at CANNAPHARMARX, INC..","evidence_excerpt":"On August 15th, 2023, the remaining members of the Board appointed Messrs. Adam Mindle and Anthony Michael Panek as members of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1081938/000168316823006113/0001683168-23-006113-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}